Influence of adrenomedullin 2/intermedin gene polymorphism on blood pressure, renal function and silent cerebrovascular lesions in Japanese : the Ohasama study

Search this Article

Author(s)

    • HIROSE Takuo
    • Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences and Medicine
    • TOTSUNE Kazuhito
    • Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences and Medicine
    • NAKASHIGE Yukiko
    • Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences and Medicine
    • METOKI Hirohito
    • Department of Obstetrics and Gynecology, Tohoku University Graduate School of Medicine
    • KIKUYA Masahiro
    • Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences and Medicine
    • OHKUBO Takayoshi
    • Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences and Medicine
    • HARA Azusa
    • Epidemiology and Prevention Division, Research Center for Cancer Prevention and Screening, National Cancer Center
    • SATOH Michihiro
    • Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences and Medicine
    • INOUE Ryusuke
    • Department of Medical Informatics, Tohoku University School of Medicine
    • ASAYAMA Kei
    • Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences and Medicine
    • KONDO Takeo
    • Department of Physical Medicine and Rehabilitation, Tohoku University Graduate School of Medicine
    • KAMIDE Kei
    • Department of Geriatric Medicine and Nephrology, Osaka University Graduate School of Medicine
    • KATSUYA Tomohiro
    • Department of Clinical Gene Therapy, Osaka University Graduate School of Medicine
    • OGIHARA Toshio
    • Osaka General Medical Center, Osaka Prefectural Hospital Organization
    • IZUMI Shin-Ichi
    • Department of Physical Medicine and Rehabilitation. Tohoku University Graduate School of Medicine
    • RAKUGI Hiromi
    • Department of Geriatric Medicine and Nephrology, Osaka University Graduate School of Medicine
    • TAKAHASHI Kazuhiro
    • Department of Endocrinology and Applied Medical Science, Tohoku University Graduate School of Medicine
    • IMAI Yutaka
    • Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences and Medicine

Journal

  • Hypertens Res

    Hypertens Res 34(12), 1327-1332, 2011-12-01

References:  47

Cited by:  1

Codes

  • NII Article ID (NAID)
    10030278155
  • NII NACSIS-CAT ID (NCID)
    AA10847079
  • Text Lang
    ENG
  • Article Type
    Journal Article
  • ISSN
    09169636
  • Data Source
    CJP  CJPref 
Page Top